Tag

Tag: graft versus host disease

bone marrow transplant blood cancer kiadis pharma cell therapy

13/11/2019 2 mins

Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial

15/05/2018 2 mins

Series B Funding Helps Dutch Biotech Fight Graft Versus Host Disease

20/09/2017 1 min

Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment

22/05/2017 7 mins

Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer

25/04/2017 2 mins

New Research could Save Patients from Graft-Versus-Host Disease

28/03/2017 2 mins

EMA Paves the Way for a New Blood Cancer Immunotherapy for Children

06/02/2017 1 min

Better and Safer Bone Marrow Transplants for Leukemia enter Phase III

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.

Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS